Abstract:Key points Spinal muscular atrophy (SMA) is a health‐ and life‐limiting neuromuscular disorder caused by a deficiency in survival motor neuron (SMN) protein. While historically considered a motor neuron disease, current understanding of SMA emphasizes its systemic nature, which requires addressing affected peripheral tissues such as skeletal muscle in particular. Chronic physical activity is beneficial for SMA patients, however the cellular and molecular mechanisms of exercise biology are largely undefined in SMA. After a single bout of exercise, canonical responses such as skeletal muscle AMPK, p38, and PGC‐1α activation were preserved in SMA‐like Smn 2B/− animals. Furthermore, molecules involved in SMN transcription were also altered following physical activity. Collectively, these changes were coincident with an increase in full‐length SMN transcription and corrective SMN pre‐mRNA splicing. Our study advances understanding of the exercise biology of SMA and highlights the AMPK‐p38‐PGC‐1α axis as a potential regulator of SMN expression in muscle. Chronic physical activity is safe and effective in spinal muscular atrophy (SMA) patients, however the underlying cellular events that drive physiological adaptations are undefined. We examined the effects of a single bout of exercise on molecular mechanisms associated with adaptive remodelling in the skeletal muscle of Smn 2B/− SMA‐like mice. Skeletal muscles were collected from healthy Smn 2B/+ mice and Smn 2B/− littermates at pre‐ [postnatal day (P) 9], early‐ (P13) and late‐symptomatic (P21) stages to characterize SMA disease progression. Muscles were also collected from Smn 2B/− animals exercised to fatigue on a motorized treadmill. Intracellular signalling and gene expression were examined using Western blotting, confocal immunofluorescence microscopy, real‐time quantitative polymerase chain reaction (PCR), and endpoint PCR assays. Basal skeletal muscle AMP‐activated protein kinase (AMPK) and p38 mitogen‐activated protein kinase (p38) expression and activity were not affected by SMA‐like conditions. Canonical exercise responses such as AMPK, p38, and peroxisome proliferator‐activated receptor γ coactivator‐1α (PGC‐1α) activation were observed following a bout of exercise in Smn 2B/− animals. Furthermore, molecules involved in survival motor neuron (SMN) transcription including protein kinase B (AKT) and extracellular signal‐regulated kinases (ERK)/ ETS‐like gene 1 (ELK), were altered following physical activity. Acute exercise was also able to mitigate aberrant proteolytic signalling in the skeletal muscle of Smn 2B/− mice. Collectively, these changes were coincident with an exercise‐evoked increase in full‐length SMN mRNA expression. This study advances our understanding of the exercise biology of SMA and highlights the AMPK‐p38‐PGC‐1α axis as a potential regulator of SMN expression alongside AKT and ERK/ELK signalling. This article is protected by copyright. All rights reserved

Exercise and disease state influence the beneficial effects of Fn14-depletion on survival and muscle pathology in the SOD1G93A amyotrophic lateral sclerosis (ALS) mouse model

Exercise, disease state and sex influence the beneficial effects of Fn14-depletion on survival and muscle pathology in the SOD1G93A amyotrophic lateral sclerosis (ALS) mouse model

Dysregulation of Tweak and Fn14 in skeletal muscle of spinal muscular atrophy mice

Exercise training induces mild skeletal muscle adaptations without altering disease progression in a TDP-43 mouse model

Overview of Impaired BDNF Signaling, Their Coupled Downstream Serine-Threonine Kinases and SNARE/SM Complex in the Neuromuscular Junction of the Amyotrophic Lateral Sclerosis Model SOD1-G93A Mice

Endurance exercise has a negative impact on the onset of SOD1-G93A ALS in female mice and affects the entire skeletal muscle-motor neuron axis

KLF15 overexpression in myocytes fails to ameliorate ALS-related pathology or extend the lifespan of SOD1G93A mice

Dysregulated FOXO1 activity drives skeletal muscle intrinsic dysfunction in amyotrophic lateral sclerosis.

Injectable borax-loaded alginate hydrogels reduce muscle atrophy, modulate inflammation, and generate neuroprotection in the SOD1 mouse model of ALS via activation of the IGF–Akt–mTOR axis pathway

FM19G11-loaded nanoparticles modulate energetic status and production of reactive oxygen species in myoblasts from ALS mice

The myokine FGF21 associates with enhanced survival in ALS and mitigates stress-induced cytotoxicity

Novel FKBP12 ligand promotes functional improvement in SOD1 ALS mice

Effects of Diet on Adenosine Monophosphate-Activated Protein Kinase Activity and Disease Progression in an Amyotrophic Lateral Sclerosis Model

Gene profiling of skeletal muscle in an amyotrophic lateral sclerosis mouse model

Physical exercise in amyotrophic lateral sclerosis: a potential co-adjuvant therapeutic option to counteract disease progression

Mechanisms of exercise‐induced survival motor neuron expression in the skeletal muscle of spinal muscular atrophy‐like mice

Swim Training Modulates Mouse Skeletal Muscle Energy Metabolism and Ameliorates Reduction in Grip Strength in a Mouse Model of Amyotrophic Lateral Sclerosis

Sigma-1 receptor agonist PRE-084 confers protection against TAR DNA-binding protein-43 toxicity through NRF2 signalling

Different outcomes of endurance and resistance exercise in skeletal muscles of Oculopharyngeal muscular dystrophy

The Potential Related Genes and Mechanisms Involved in Improving the Treadmill Exercise Ability of APP/PS1 Mice

Beneficial and Sexually Dimorphic Response to Combined HDAC Inhibitor Valproate and AMPK/SIRT1 Pathway Activator Resveratrol in the Treatment of ALS Mice